Bayer Submits Application To EMA For Third Indication Of Darolutamide

A vibrant aerial view of the rural landscape in Switzerland with a sports stadium and lush greenery.

RTTNews) – Bayer announced the submission of an application to the European Medicines Agency for the oral androgen receptor inhibitor darolutamide. The company is seeking approval for the use of darolutamide in combination with androgen deprivation therapy in patients with metas…
Read More

Stunning view of Olympiaturm tower during sunset in Munich's Olympic Park, Germany.
Photo: MC Brillo / Pexels
AdvertisementDon't Outlive Your Benefits — Long-Term Care insurance with unlimited LTC funds for as long as you live. Call 1-800-317-0625
Teenager using futuristic touchscreen technology indoors, wearing safety goggles.
Photo: Vika Glitter / Pexels
AdvertisementDon't Outlive Your Benefits — Long-Term Care insurance with unlimited LTC funds for as long as you live. Call 1-800-317-0625
AdvertisementDon't Outlive Your Benefits — Long-Term Care insurance with unlimited LTC funds for as long as you live. Call 1-800-317-0625
AdvertisementDon't Outlive Your Benefits — Long-Term Care insurance with unlimited LTC funds for as long as you live. Call 1-800-317-0625

Join the conversation

Your email address will not be published. Be respectful — keep it constructive.

AdvertisementDon't Outlive Your Benefits — Long-Term Care insurance with unlimited LTC funds for as long as you live. Call 1-800-317-0625
AdvertisementDon't Outlive Your Benefits — Long-Term Care insurance with unlimited LTC funds for as long as you live. Call 1-800-317-0625